Problematic blood clotting contributes to Alzheimer’s disease (w/ Video)

June 16, 2010

( -- Alzheimer's disease isn't just about twisted brain cells. It's also about the blood vessels that feed those neurons. New research at Rockefeller University has shown how the most common element of the plaque deposits found outside the brain cells of Alzheimer’s patients interacts with a blood clotting agent and causes clots to form faster and become harder to break down. The scientists suggest new drugs that would target this association could potentially treat what is increasingly recognized as a crucial element of the disease, the vascular component.

Alzheimer’s disease has long been studied primarily as a disease of . But researchers have now shown how the disease may be damaging the brain by choking off blood flow. In experiments published June 10 in Neuron, scientists at Rockefeller University reveal that amyloid-β, which builds up around in Alzheimer’s patients, interacts with a common blood clotting agent to increase clotting in the arteries that feed the brain. Such activity could cut off blood flow to neurons, suffocating them over time. A drug that interferes with that process could reduce the memory loss and dementia that are the most wrenching consequences of the disease, the findings suggest.

“There’s at least this one very promising therapeutic angle,” says Sidney Strickland, head of the Laboratory of Neurobiology and Genetics at Rockefeller. “And
what’s nice is that a drug that disrupted this particular interaction would not affect clotting elsewhere like regular anticoagulants, because the amyloid-β peptide is primarily found in the brain.”

This video is not supported by your browser at this time.

Postdoctoral fellow Marta Cortes-Canteli led the work in Strickland’s lab, conducting test tube experiments and experiments in mice genetically engineered with Alzheimer’s disease to investigate the interaction of amyloid-β and the agent called fibrinogen. Normally, when the body is injured, fibrinogen forms fibrin clots to stop uncontrolled bleeding. Once the wound is healed, the blood clot is broken down and blood flow returns to normal.

Strickland, Cortes-Canteli and colleagues found that the blood in mice with the extra amyloid-β produced in Alzheimer’s disease clotted more quickly and that the clots were more difficult to degrade. They also found that mice with lower levels of fibrinogen had less buildup of amyloid beta in the walls of their and performed better on memory tasks.

This led them to propose a new model for the vascular component of the disease, which is increasingly recognized as a key element in its pathology. “The promotion of blood clots and the difficulty of breaking them down would cause a decrease in cerebral and increase in inflammation that could eventually lead to the neuronal dysfunction in Alzheimer’s patients,” Cortes-Canteli says. “Of course, Alzheimer’s is a multifaceted disease, and a lot of things are going on, but we do think that targeting the association of amyloid-β and fibrinogen could be a very promising treatment.”

Explore further: Blood-clotting protein may be new target for Alzheimer's drugs

More information: Marta Cortes-Canteli et al., Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer’s Disease, Neuron 66: 695-705 (June 10, 2010)

Related Stories

Research illuminates link between Alzheimer's and stroke

March 17, 2008

For years, neuroscientists have known that the risk of Alzheimer’s disease is nearly doubled among people who have had a stroke. Now researchers at Columbia University Medical Center have found a process in the brain that ...

Study links diabetes and Alzheimer's disease

April 30, 2008

Diabetic individuals have a significantly higher risk of developing Alzheimer’s disease but the molecular connection between the two remains unexplained. Now, researchers at the Salk Institute for Biological Studies identified ...

Blood flow in Alzheimer's disease

July 27, 2009

Researchers have discovered that the enzyme, endothelin converting enzyme-2 (ECE-2), may cause the decrease in blood flow in the brain seen in Alzheimer's disease and contribute to progression of the disease.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

( -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.